In addition, the Commission’s detailed analysis of availability of supply for all product categories of medical devices (at six-digit HS code level for all medical devices) using the parameters described above, suggests that Union manufacturers of medical devices have the necessary capacity to ensure alternative sources of supply. In particular, Union manufacturers would only need to redirect 3 % to 4 % of their current exports to substitute all medical devices imported from the PRC potentially excluded from Union procurement procedures. On the basis of this analysis, the Commission determined that the Union contracting authorities and contracting entities would have a large variety of alternative sources of supply (which include both Union and imported medical devices) for all categories of medical devices to replace the medical devices originating in the PRC that would be impacted by the IPI measure. In conclusion, the adoption of the IPI measure determined in recital 33 would not create shortages or significantly reduce the supply of medical devices for Union contracting authorities and contracting entities as the Union would still dispose of alternative sources of supply, which would be sufficient to address the public procurement demand.
42 2. DETERMINATION OF THE IPI MEASURE › 2.2. Availability of alternative sources of supply, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025